Drug Immunology

Vyvgart

Payments companies reported to CMS as associated with Vyvgart. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$5.8Massociated payments (2023-2025)
7,054clinicians with associated payments
1company reporting

By year

2023 $2.4M
2024 $1.5M
2025 $1.9M

Payments reported as associated with Vyvgart, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Neurology (Psychiatry & Neurology) $3.4M
Neuromuscular Medicine (Psychiatry & Neurology) $915K
Clinical Neurophysiology $200K
Dermatology $178K
Rheumatology $141K
Family $93K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Vyvgart

These are the largest totals companies reported as associated with Vyvgart. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Tuan Vu Tampa, FL Neurology (Psychiatry & Neurology) $171,864.78
Raghav Govindarajan O Fallon, IL Neuromuscular Medicine (Psychiatry & Neurology) $149,242.81
Jeffery Allen Minneapolis, MN Neurology (Psychiatry & Neurology) $123,128.40
Samir Macwan Rancho Mirage, CA Neuromuscular Medicine (Psychiatry & Neurology) $121,741.44
Andrew Gordon Lake Barrington, IL Neurology (Psychiatry & Neurology) $120,498.66
Nicholas Silvestri Buffalo, NY Neuromuscular Medicine (Psychiatry & Neurology) $117,298.61
Rossitza Chichkova Tampa, FL Neurology (Psychiatry & Neurology) $110,695.68
Suraj Muley Phoenix, AZ Neurology (Psychiatry & Neurology) $109,720.71
Barry Vaught Crab Orchard, WV Neurology (Psychiatry & Neurology) $108,843.88
Chafic Karam Portland, OR Neurology (Psychiatry & Neurology) $99,650.62

Prescribed Vyvgart?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.